Clinical trial
Horse Chestnut Seed Extract for Lymphedema
NCT00213928 · University of Wisconsin, Madison, Other · Completed
Key facts
| NCT number | NCT00213928 |
|---|---|
| Title | Horse Chestnut Seed Extract for Lymphedema |
| Official title | A Single-blind, Randomized Trial of Horse Chestnut Seed Extract for the Treatment of Lymphedema of the Arm in Breast Cancer Survivors |
| Lead sponsor | University of Wisconsin, Madison, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Lymphedema of Arm |
| Intervention type | Drug |
| Interventions | Horse Chestnut Seed Extract |
| Enrollment | 56 |
| Start date | May 1, 2002 |
| Primary completion | Sep 1, 2004 |
| Completion | Sep 1, 2008 |
| First posted | Sep 21, 2005 |
| Last update posted | Jun 2, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: